GGrantIndex
← Leaderboards

K Kian Ang

University Of Texas Md Anderson Can Ctr

$2,378,003
Attributed
$2,378,003
Total exposure
4
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.8M · FY200512
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$13,386,323 · 5

By mechanism

P01$12,242,352 · 3
R01$1,143,971 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Neoplasm /Cancer Radiation Therapy

Research focus

Neoplasm /Cancer Radiation TherapyHuman SubjectClinical ResearchBiomarkerGrowth Factor ReceptorsHuman Therapy EvaluationHead /Neck NeoplasmNeoplasm /Cancer ChemotherapyMolecularTumorResearch PersonnelRadiationRadiation SensitivityNormal Tissue MorphologyRadiation TherapyResponseBlood VesselsPre-ClinicalEpidermal Growth FactorEpidermal Growth Factor ReceptorPathway InteractionsDoseChemotherapyIn Vivo

Grant awards (23)

Extension of Radiotherapy Research$291,567
R01 · FY2012 · CA · contact PI
Extension of Radiotherapy Research$290,499
R01 · FY2011 · CA · contact PI
Extension of Radiotherapy Research$300,000
P01 · FY2009 · CA · contact PI
Extension of Radiotherapy Research$1,516,143
P01 · FY2008 · CA · contact PI
MOLECULAR TARGETED COMBINED THERAPY$238,311
P01 · FY2008 · CA · contact PI
Extension of Radiotherapy Research$1,506,020
P01 · FY2007 · CA · contact PI
MOLECULAR TARGETED COMBINED THERAPY$237,278
P01 · FY2007 · CA · contact PI
Extension of Radiotherapy Research$1,510,861
P01 · FY2006 · CA · contact PI
MOLECULAR TARGETED COMBINED THERAPY$137,539
P01 · FY2006 · CA · contact PI
Extension of Radiotherapy Research$1,507,300
P01 · FY2005 · CA
MOLECULAR TARGETED COMBINED THERAPY$134,319
P01 · FY2005 · CA
Extension of Radiotherapy Research$1,428,308
P01 · FY2004 · CA
CORE C: THE ADMINISTRATIVE CORE$145,611
P01 · FY2004 · CA
MOLECULAR TARGETED COMBINED THERAPY$130,610
P01 · FY2004 · CA
EXTENSION OF RADIOTHERAPY RESEARCH$568,076
P01 · FY2002 · CA
PROGNOSTIC BIOMARKERS FOR HEAD AND NECK CANCER$206,548
R01 · FY2002 · CA
RADIATION RESPONSE WITH NUCLEOSIDE ANALOGS BY INHIBITING REPOPULATION &REPAIR$0
P01 · FY2002 · CA
EXTENSION OF RADIOTHERAPY RESEARCH$1,343,483
P01 · FY2001 · CA
PROGNOSTIC BIOMARKERS FOR HEAD AND NECK CANCER$179,759
R01 · FY2001 · CA
RADIATION RESPONSE WITH NUCLEOSIDE ANALOGS BY INHIBITING REPOPULATION &REPAIR$0
P01 · FY2001 · CA
EXTENSION OF RADIOTHERAPY RESEARCH$1,328,129
P01 · FY2000 · CA
RADIATION RESPONSE WITH NUCLEOSIDE ANALOGS BY INHIBITING REPOPULATION &REPAIR$210,364
P01 · FY2000 · CA
PROGNOSTIC BIOMARKERS FOR HEAD AND NECK CANCER$175,598
R01 · FY2000 · CA